Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation

doi:10.4254/wjh.v18.i1.113429

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

(41)

(43)

(0)

(10)

(596)

(4)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Hepatol. Jan 27, 2026; 18(1): 113429
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113429

Full Size Figure Download Figure

Figure 3 Receiver operating characteristic curve evaluating the predictive performance of the interleukin-6/interleukin-10 ratio for immune dysregulation following radiofrequency ablation. AUC: Area under the receiver operating characteristic curve.

Citation: Pang L, Tang D, Zhou WL, Bai X, Zhao HJ, Wang LQ, Cheng W, Wu BL. Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation. World J Hepatol 2026; 18(1): 113429
URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113429.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113429

Pang L, Tang D, Zhou WL, Bai X, Zhao HJ, Wang LQ, Cheng W, Wu BL. Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation. World J Hepatol 2026; 18(1): 113429 [PMID: 41640970 DOI: 10.4254/wjh.v18.i1.113429]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.